Tools

LEADER 03505cam a2200649 a 4500

001 ocn463970952;

003 OCoLC;

005 20141212075118.0;

008 091106s2010 njua b 001 0 eng ;

010 a| 2009044230;

015 a| GBB0068722| bnb;

016 7 a| 0154682672| Uk;

016 7 a| 1015342162| DNLM;

020 a| 9780691141794 (acid-free paper);

020 a| 0691141797 (acid-free paper);

020 a| 9780691141800 (pbk. : acid-free paper);

020 a| 0691141800 (pbk. : acid-free paper);

020 a| 9781400835119 (e-book);

020 a| 1400835119 (e-book);

029 1 a| CDXb| 11262398;

029 1 a| CDXb| 11262399;

029 1 a| NLGGCb| 324074077;

029 1 a| GEBAYb| 11738428;

029 1 a| NLMb| 101534216;

029 1 a| AU@b| 000044960619;

029 1 a| AU@b| 000046687705;

035 a| (Sirsi) o463970952;

035 a| (OCoLC)463970952;

043 a| n-us---;

049 a| EREE;

050 00 a| RA401.A3b| C37 2010;

082 00 a| 362.17/822| 22;

084 a| 44.142| bcl;

100 1 a| Carpenter, Daniel P.,d| 1967-=| ^A491764;

245 10 a| Reputation and power :b| organizational image and pharmaceutical regulation at the FDA /c| Daniel Carpenter.;

300 a| xx, 802 pages :b| illustrations ;c| 25 cm.;

336 a| text2| rdacontent;

337 a| unmediated2| rdamedia;

338 a| volume2| rdacarrier;

490 1 a| Princeton studies in American politics : historical, international, and comparative perspectives;

504 a| Includes bibliographical references (p. [753]-757) and index.;

505 00 g| Introduction :t| The gatekeeper --t| Reputation and regulatory power --t| Reputation and gatekeeping authority : the federal Food, Drug, and Cosmetic Act of 1938 and its aftermath --t| The ambiguous emergence of American pharmaceutical regulation, 1944-1961 --t| Reputation and power crystallized : thalidomide, Frances Kelsey, and phased experiment, 1961-1966 --t| Reputation and power institutionalized : scientific networks, congressional hearings, and judicial affirmations, 1963-1986 --t| Reputation and power contested : emboldened audiences in cancer and AIDS, 1977-1992 --t| Reputation and the organizational politics of new drug review --t| The governance of research and development : gatekeeping power, conceptual guidance, and regulation by satellite --t| The other side of the gate : reputation, power, and post-market regulation --t| The détenté of firm and regulator --t| American pharmaceutical regulations in international context : audiences, comparisons, and dependencies --g| Conclusion :t| A reputation in brief.;

610 10 a| United States.b| Food and Drug Administration.=| ^A1253;

650 0 a| Pharmaceutical policyz| United States.=| ^A139729;

650 0 a| Drugsx| Researchz| United States.=| ^A1001118;

830 0 a| Princeton studies in American politics.=| ^A308870;

949 a| RA401.A3 C37 2010h| JOYNER48o| jmpli| 30372015830513;

938 a| YBP Library Servicesb| YANKn| 3164052;

938 a| Blackwell Book Serviceb| BBUSn| R3844866c| $75.00;

938 a| Coutts Information Servicesb| COUTn| 11262398;

938 a| Midwest Library Servicesb| MWSTn| 02347822010;

994 a| C0b| ERE;

596 a| 1;

998 a| 2657116;

999 a| RA401.A3 C37 2010w| LCc| 1i| 30372015830513d| 11/14/2019e| 6/27/2019f| 2/13/2012g| 1l| JGESm| JOYNERn| 2q| 1r| Ys| Yt| JGESBKu| 1/6/2012x| BOOKz| JSTACKSo| .STAFF. jmpl;

Reputation and power : organizational image and pharmaceutical regulation at the FDA / Daniel Carpenter.

Author/creator	Carpenter, Daniel P., 1967-
Format	Book
Publication Info	Princeton : Princeton University Press, ©2010.
Description	xx, 802 pages : illustrations ; 25 cm.
Subjects	United States. Food and Drug Administration. Pharmaceutical policy--United States. Drugs--Research. --United States.

Series	Princeton studies in American politics : historical, international, and comparative perspectives Princeton studies in American politics. ^A308870
Contents	Introduction : The gatekeeper -- Reputation and regulatory power -- Reputation and gatekeeping authority : the federal Food, Drug, and Cosmetic Act of 1938 and its aftermath -- The ambiguous emergence of American pharmaceutical regulation, 1944-1961 -- Reputation and power crystallized : thalidomide, Frances Kelsey, and phased experiment, 1961-1966 -- Reputation and power institutionalized : scientific networks, congressional hearings, and judicial affirmations, 1963-1986 -- Reputation and power contested : emboldened audiences in cancer and AIDS, 1977-1992 -- Reputation and the organizational politics of new drug review -- The governance of research and development : gatekeeping power, conceptual guidance, and regulation by satellite -- The other side of the gate : reputation, power, and post-market regulation -- The détenté of firm and regulator -- American pharmaceutical regulations in international context : audiences, comparisons, and dependencies -- Conclusion : A reputation in brief.
Bibliography note	Includes bibliographical references (p. [753]-757) and index.
LCCN	2009044230
ISBN	9780691141794 (acid-free paper)
ISBN	0691141797 (acid-free paper)
ISBN	9780691141800 (pbk. : acid-free paper)
ISBN	0691141800 (pbk. : acid-free paper)
ISBN	9781400835119 (e-book)
ISBN	1400835119 (e-book)

Availability

Library	Location	Call Number	Status	Item Actions
Joyner	General Stacks	RA401.A3 C37 2010	✔ Available	Place Hold

Reputation and power : organizational image and pharmaceutical regulation at the FDA / Daniel Carpenter.

Click here for more information about this title

Availability